Cargando…

Association Between Hypnotic Use and All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease and Insomnia

PURPOSE: Hypnotics are commonly prescribed in patients with COPD to manage insomnia. Given the considerable risks associated with these drugs, the aim of the study was to evaluate the risk of all-cause mortality associated with hypnotics in a cohort of veterans with COPD presenting with insomnia. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Solh, Ali A, Lawson, Yolanda, Wilding, Gregory E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629458/ https://www.ncbi.nlm.nih.gov/pubmed/37942297 http://dx.doi.org/10.2147/COPD.S430609

Ejemplares similares

All-cause mortality in COVID-19 patients receiving statin therapy: analysis of veterans affairs database cohort study
por: El-Solh, Ali A., et al.
Publicado: (2021)

Sleep, Insomnia and Hypnotics
Publicado: (1892)

Use and Abuse of Hypnotics in Insomnia
Publicado: (1899)

Comparison of in-hospital mortality risk prediction models from COVID-19
por: El-Solh, Ali A., et al.
Publicado: (2020)

Factors Associated with Long-Term Use of Hypnotics among Patients with Chronic Insomnia
por: Takaesu, Yoshikazu, et al.
Publicado: (2014)

Discontinuation of hypnotics during cognitive behavioural therapy for insomnia
por: Zavesicka, Lucie, et al.
Publicado: (2008)

People with insomnia: experiences with sedative hypnotics and risk perception
por: Cheung, Janet M. Y., et al.
Publicado: (2015)

Cognitive Behavioral Therapy for Insomnia Reduces Hypnotic Prescriptions
por: Park, Kyung Mee, et al.
Publicado: (2018)

Risk of insomnia and hypnotics use among emergency physicians
por: LIOU, Yih-Farng, et al.
Publicado: (2020)

The Difference in All-Cause Mortality Between Allergic Bronchopulmonary Aspergillosis with and without Chronic Obstructive Pulmonary Disease
por: Zhang, Ping’an, et al.
Publicado: (2022)

Plasma YKL-40 and all-cause mortality in patients with chronic obstructive pulmonary disease
por: Holmgaard, Dennis B, et al.
Publicado: (2013)

Development and acceptability of a decision aid for chronic insomnia considering discontinuation of benzodiazepine hypnotics
por: Aoki, Yumi, et al.
Publicado: (2021)

Difference in spectral power density of sleep electroencephalography between individuals without insomnia and frequent hypnotic users with insomnia complaints
por: Kang, Jae Myeong, et al.
Publicado: (2022)

Sedative and hypnotic effects of Iranian traditional medicinal herbs used for treatment of insomnia
por: Andalib, Sasan, et al.
Publicado: (2011)

Association between the course of hypnotics treatment for insomnia and work functioning impairment in Japanese workers
por: Okawara, Makoto, et al.
Publicado: (2020)

Association Between Non-obstructive Chronic Bronchitis and Incident Chronic Obstructive Pulmonary Disease and All-Cause Mortality: A Systematic Review and Meta-Analysis
por: Wu, Fan, et al.
Publicado: (2022)

Aortic Pulse Wave Velocity Predicts All-Cause Mortality in Chronic Obstructive Pulmonary Disease
por: Fisk, Marie, et al.
Publicado: (2020)

U-Shaped Relationship Between Serum Lactate Dehydrogenase with All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease
por: Huang, Lihua, et al.
Publicado: (2023)

P073 Co-morbid insomnia and obstructive sleep apnoea is associated with all-cause mortality and cardiovascular event risk
por: Lechat, B, et al.
Publicado: (2021)

Pharmacists' interventions to reduce sedative/hypnotic use for insomnia in hospitalized patients
por: Badr, Aisha F., et al.
Publicado: (2018)

Sedative and hypnotic effects of compound Anshen essential oil inhalation for insomnia
por: Zhong, Yu, et al.
Publicado: (2019)

Paradoxical Insomnia in a Frustrated Patient Treated With Hypnotics for Ten Years
por: Wasey, Waiz, et al.
Publicado: (2021)

Physicians’ attitudes toward hypnotics for insomnia: A questionnaire-based study
por: Takeshima, Masahiro, et al.
Publicado: (2023)

Prevalence of insomnia and hypnotic use in Norwegian patients visiting their general practitioner
por: Torsvik, Sunniva, et al.
Publicado: (2022)

Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease
por: Lipson, David A., et al.
Publicado: (2020)

GOLD Classifications, COPD Hospitalization, and All-Cause Mortality in Chronic Obstructive Pulmonary Disease: The HUNT Study
por: Bhatta, Laxmi, et al.
Publicado: (2020)

On-the-road driving performance and driving-related skills in older untreated insomnia patients and chronic users of hypnotics
por: Leufkens, T. R. M., et al.
Publicado: (2014)

Predicting Hypnotic Use among Insomnia Patients with the Theory of Planned Behavior and Craving
por: Yang, Chien-Ming, et al.
Publicado: (2022)

Alliance for Sleep Clinical Practice Guideline on Switching or Deprescribing Hypnotic Medications for Insomnia
por: Watson, Nathaniel F., et al.
Publicado: (2023)

Insomnia in chronic obstructive pulmonary disease and associations with healthcare utilization and costs
por: Luyster, Faith S., et al.
Publicado: (2023)

Inhaled anticholinergic use and all-cause mortality among elderly Medicare beneficiaries with chronic obstructive pulmonary disease
por: Ajmera, Mayank, et al.
Publicado: (2013)

Impact of Frailty on the Risk of Exacerbations and All-Cause Mortality in Elderly Patients with Stable Chronic Obstructive Pulmonary Disease
por: Luo, Jia, et al.
Publicado: (2021)

Treatment of insomnia in myasthenia gravis—A prospective study on non-benzodiazepine hypnotics in the treatment of myasthenia gravis patients with insomnia
por: Yan, Jingwen, et al.
Publicado: (2023)

Comparison of the Use of Hypnotic in Psychiatric Patients with Insomnia at the Mental Health Centre Prolet in Skopje
por: Isjanovski, Viktor, et al.
Publicado: (2019)

Management of Hypnotics in Patients with Insomnia and Heart Failure during Hospitalization: A Systematic Review
por: Jorge-Samitier, Pablo, et al.
Publicado: (2021)

Reply to Fisk and Wilkinson: Aortic Pulse Wave Velocity Predicts All-Cause Mortality in Chronic Obstructive Pulmonary Disease
por: Crim, Courtney, et al.
Publicado: (2020)

Clinical characteristics and risk of all-cause mortality in low education patients with chronic obstructive pulmonary disease in the Chinese population
por: Song, Qing, et al.
Publicado: (2023)

The Value of Hypnotism in Chronic Alcoholism
Publicado: (1893)

Association Between Neutrophil-Lymphocyte Ratio and All-Cause Mortality in Critically Ill Patients with Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study
por: Hao, Shujie, et al.
Publicado: (2023)

Statins reduce all-cause mortality in chronic obstructive pulmonary disease: a systematic review and meta-analysis of observational studies
por: Horita, Nobuyuki, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_f2vk1mmm5154og6cii5tqhvdn9